Azithromycin and ceftriaxone verses ceftriaxone alone in a case of prelabour cesarean birth to decrease surgical site infection

Randomised controlled trial between single dose Azithromycin and ceftriaxone verses ceftriaxone alone in a case of prelabour cesarean birth to decrease surgical site infection - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065067

Enrollment

1980

Registered

2024-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O860- Infection of obstetric surgical wound

Interventions

Intervention1: Intravenous Azithromycin and ceftriaxone: Azithro 500 mg and ceftriaxone 1gm both intravenous Control Intervention1: On ceftriaxone: Ceftriaxone 1gm stat

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant after 37 weeks with indication breech, previous c-ection, placenta previa

Exclusion criteria

Exclusion criteria: Allergy to Azithromycin,contraindications,women in active labour, preterm labour,twins ,Maternal condition

Design outcomes

Primary

Measure	Time frame
1. Reduce surgical site infection 2.reduce endometritis 3.improve maternal and neonatal outcomes 4.safety profileTimepoint: Once weekly	—

Secondary

Measure	Time frame
Evidence based practice Advancement of knowledgeTimepoint: Evidence based practice according to response Advancement of knowledge side effects weekly	—

Countries

India

Contacts

Public ContactProf Gouri Sankar kamilya

Institute of postgraduate medical education and research Kolkata

drgkamilya@gmail.com9433122643

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026